Blackstone, TPG Complete $17.2B Acquisition of Hologic

The private equity firms have secured financing and regulatory approvals for the deal.

Apr. 7, 2026 at 3:38pm

Got story updates? Submit your updates here. ›

A highly polished, metallic medical device or diagnostic tool floating on a clean, white background, captured in a dramatic studio lighting setup that emphasizes the object's precision and innovation.The acquisition of Hologic by Blackstone and TPG signals private equity's growing interest in advanced medical technologies.Marlborough Today

Funds managed by Blackstone Inc., TPG Global, LLC, along with Abu Dhabi Investment Authority and GIC Private Limited, have completed their $17.2 billion acquisition of medical diagnostics firm Hologic, Inc. The deal, first announced in October 2025, received shareholder and regulatory approvals, including from China and the European Union.

Why it matters

The acquisition of Hologic, a major player in women's health and diagnostic testing, marks a significant move by Blackstone and TPG to expand their healthcare portfolio. It also signals continued private equity interest in the medical technology sector.

The details

Under the terms of the deal, Hologic shareholders will receive $76 per share in cash, plus a contingent value right of up to $3 per share based on revenue milestones. Blackstone and TPG have secured $12.25 billion in debt financing from major banks to fund the transaction. Hologic will maintain its headquarters in Marlborough, Massachusetts and continue operating under the Hologic name and brand.

  • The deal was first announced on October 21, 2025.
  • Hologic shareholders approved the merger on February 5, 2026.
  • The European Commission approved the acquisition on February 16, 2026.
  • The transaction closed on April 7, 2026.

The players

Blackstone Inc.

A global investment firm and one of the world's largest alternative asset managers.

TPG Global, LLC

A leading global alternative asset firm with investments across private equity, growth equity, real estate, and other asset classes.

Hologic, Inc.

A medical technology company focused on women's health and diagnostic testing.

José (Joe) E. Almeida

The newly appointed Chief Executive Officer of Hologic, succeeding Stephen MacMillan.

Got photos? Submit your photos here. ›

What they’re saying

“We are excited to partner with Hologic's talented team to build on the company's strong foundation and drive continued innovation and growth.”

— José (Joe) E. Almeida, Chief Executive Officer, Hologic

What’s next

Hologic will continue operating under its existing brand and leadership, with a focus on expanding its diagnostic testing and women's health product offerings.

The takeaway

The Hologic acquisition demonstrates Blackstone and TPG's continued appetite for healthcare investments, as private equity firms seek to capitalize on the growing demand for medical technologies and diagnostics.